159 related articles for article (PubMed ID: 23180110)
1. A method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure.
Walsh L; Schneider U
Radiat Environ Biophys; 2013 Mar; 52(1):135-45. PubMed ID: 23180110
[TBL] [Abstract][Full Text] [Related]
2. Solid cancer incidence in atomic bomb survivors: 1958-1998.
Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
[TBL] [Abstract][Full Text] [Related]
3. Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study.
Leuraud K; Richardson DB; Cardis E; Daniels RD; Gillies M; Haylock R; Moissonnier M; Schubauer-Berigan MK; Thierry-Chef I; Kesminiene A; Laurier D
Radiat Environ Biophys; 2021 Mar; 60(1):23-39. PubMed ID: 33479781
[TBL] [Abstract][Full Text] [Related]
4. Cancer incidence risks above and below 1 Gy for radiation protection in space.
Hafner L; Walsh L; Schneider U
Life Sci Space Res (Amst); 2021 Feb; 28():41-56. PubMed ID: 33612179
[TBL] [Abstract][Full Text] [Related]
5. Multi-model inference of adult and childhood leukaemia excess relative risks based on the Japanese A-bomb survivors mortality data (1950-2000).
Walsh L; Kaiser JC
Radiat Environ Biophys; 2011 Mar; 50(1):21-35. PubMed ID: 20931336
[TBL] [Abstract][Full Text] [Related]
6. Radiation risk models for all solid cancers other than those types of cancer requiring individual assessments after a nuclear accident.
Walsh L; Zhang W
Radiat Environ Biophys; 2016 Mar; 55(1):9-17. PubMed ID: 26732943
[TBL] [Abstract][Full Text] [Related]
7. Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.
Walsh L
Radiat Environ Biophys; 2013 Mar; 52(1):29-36. PubMed ID: 23161400
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
[TBL] [Abstract][Full Text] [Related]
9. Dose response and temporal patterns of radiation-associated solid cancer risks.
Preston DL; Pierce DA; Shimizu Y; Ron E; Mabuchi K
Health Phys; 2003 Jul; 85(1):43-6. PubMed ID: 12852470
[TBL] [Abstract][Full Text] [Related]
10. The influence of follow-up on DS02 low-dose ranges with a significant excess relative risk of all solid cancer in the Japanese A-bomb survivors.
Walsh L; Schneider U
Radiat Environ Biophys; 2016 Nov; 55(4):509-515. PubMed ID: 27586509
[TBL] [Abstract][Full Text] [Related]
11. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
13. Comparison and multi-model inference of excess risks models for radiation-related solid cancer.
Stabilini A; Hafner L; Walsh L
Radiat Environ Biophys; 2023 Mar; 62(1):17-34. PubMed ID: 36680572
[TBL] [Abstract][Full Text] [Related]
14. Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor.
Shore R; Walsh L; Azizova T; Rühm W
Int J Radiat Biol; 2017 Oct; 93(10):1064-1078. PubMed ID: 28421857
[TBL] [Abstract][Full Text] [Related]
15. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors.
Grant EJ; Ozasa K; Preston DL; Suyama A; Shimizu Y; Sakata R; Sugiyama H; Pham TM; Cologne J; Yamada M; De Roos AJ; Kopecky KJ; Porter MP; Seixas N; Davis S
Radiat Res; 2012 Jul; 178(1):86-98. PubMed ID: 22631857
[TBL] [Abstract][Full Text] [Related]
16. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
[TBL] [Abstract][Full Text] [Related]
17. Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.
Jacob P; Walsh L; Eidemüller M
Radiat Environ Biophys; 2008 Jul; 47(3):375-88. PubMed ID: 18481074
[TBL] [Abstract][Full Text] [Related]
18. Age effects on radiation response: summary of a recent symposium and future perspectives.
Little MP; Brenner AV; Grant EJ; Sugiyama H; Preston DL; Sakata R; Cologne J; Velazquez-Kronen R; Utada M; Mabuchi K; Ozasa K; Olson JD; Dugan GO; Pazzaglia S; Cline JM; Applegate KE
Int J Radiat Biol; 2022 May; ():1-11. PubMed ID: 35394411
[TBL] [Abstract][Full Text] [Related]
19. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
20. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
